Laboratory of Pharmacology and Toxicology, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, Japan.
Brain Res. 2012 Dec 7;1488:113-22. doi: 10.1016/j.brainres.2012.09.042. Epub 2012 Oct 3.
The blood-brain barrier (BBB) is formed by brain microvascular endothelial cells (BMEC) working together with astrocytes and pericytes, in which tight junctions and various transporters strictly regulate the penetration of diverse compounds into the brain. Clarification of the molecular machinery that provides such regulation using in vitro BBB models has provided important insights into the roles of the BBB in central nervous system (CNS) disorders and CNS drug development. In this study, we succeeded in establishing a new cell line, hereinafter referred to as human BMEC/conditionally immortalized, clone β (HBMEC/ciβ), as part of our ongoing efforts to develop an in vitro human BBB model. Our results showed that HBMEC/ciβ proliferated well. Furthermore, we found that HBMEC/ciβ exhibited the barrier property of restricting small molecule intercellular penetration and possessed effective efflux transporter functions, both of which are essential to a functioning BBB. Because higher temperatures are known to terminate immortalization signals, we specifically examined the effects of higher temperatures on the HBMEC/ciβ differentiation status. The results showed that higher temperatures stimulated HBMEC/ciβ differentiation, marked by morphological alteration and increases in several mRNA levels. To summarize, our data indicates that the newly established HBMEC/ciβ offers a promising tool for use in the development of a practical in vitro human BBB model that could make significant contributions toward understanding the molecular biology of CNS disorders, as well as to CNS drug development. It is also believed that the development of a specific culture method for HBMEC/ciβ will add significant value to the HBMEC/ciβ-based BBB model.
血脑屏障 (BBB) 由脑微血管内皮细胞 (BMEC) 与星形胶质细胞和周细胞共同形成,其中紧密连接和各种转运体严格调节各种化合物进入大脑的渗透。使用体外 BBB 模型阐明提供这种调节的分子机制,为 BBB 在中枢神经系统 (CNS) 疾病和 CNS 药物开发中的作用提供了重要的见解。在这项研究中,我们成功地建立了一种新的细胞系,以下简称人 BMEC/条件永生化,克隆 β (HBMEC/ciβ),作为我们开发体外人 BBB 模型的持续努力的一部分。我们的结果表明 HBMEC/ciβ 增殖良好。此外,我们发现 HBMEC/ciβ 表现出限制小分子细胞间渗透的屏障特性,并具有有效的外排转运体功能,这两者都是正常 BBB 所必需的。因为已知较高的温度会终止永生化信号,所以我们专门研究了较高温度对 HBMEC/ciβ 分化状态的影响。结果表明,较高的温度刺激 HBMEC/ciβ 分化,表现为形态改变和几种 mRNA 水平的增加。总之,我们的数据表明,新建立的 HBMEC/ciβ 为开发实用的体外人 BBB 模型提供了有前途的工具,这将对理解 CNS 疾病的分子生物学以及 CNS 药物开发做出重大贡献。人们还相信,为 HBMEC/ciβ 开发特定的培养方法将为基于 HBMEC/ciβ 的 BBB 模型增加重要价值。